Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance

Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance

Bibliographic Details
Main Author:	Mariana Verdelho Machado
Format:	Article
Language:	English
Published:	Karger Publishers 2017-07-01
Series:	GE: Portuguese Journal of Gastroenterology
Subjects:	Steatosis Controlled attenuation parameter Chronic hepatic disease
Online Access:	http://www.karger.com/Article/FullText/478944

Similar Items

Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
by: Giovanna Ferraioli, et al.
Published: (2017-05-01)

Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients
by: Mengyun Wang, et al.
Published: (2024-02-01)

The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice
by: Yi-Hao Yen, et al.
Published: (2017-11-01)

Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis
by: Rasha AlShaalan, et al.
Published: (2015-01-01)

The ultrasound‐guided attenuation parameter is useful in quantification of hepatic steatosis in non‐alcoholic fatty liver disease
by: Yu Ogino, et al.
Published: (2021-08-01)

Impact of hepatic steatosis on treatment response of autoimmune hepatitis: A retrospective multicentre analysis
by: Peiyan Liu, et al.
Published: (2022-12-01)

The association between serum folate and ultrasound - defined hepatic steatosis
by: Xingxing Chen, et al.
Published: (2023-12-01)

Attenuation Imaging with Ultrasound as a Novel Evaluation Method for Liver Steatosis
by: Po-Ke Hsu, et al.
Published: (2021-03-01)

Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases
by: Silja Steinmann, et al.
Published: (2023-12-01)

Dietary inflammatory potential is associated with higher odds of hepatic steatosis in US adults: a cross-sectional study
by: Hu Yang, et al.
Published: (2023-12-01)

Severe Hepatic Steatosis Is Associated With Low-Level Viremia and Advanced Fibrosis in Patients With Chronic Hepatitis B in North America
by: Hin Hin Ko, et al.
Published: (2022-01-01)

Feasibility of Ultrasound Attenuation Imaging for Assessing Pediatric Hepatic Steatosis
by: Kyungchul Song, et al.
Published: (2022-07-01)

Association of Serum Fibroblast Growth Factor 23 Levels with the Presence and Severity of Hepatic Steatosis Is Independent of Sleep Duration in Patients with Diabetes
by: Hu X, et al.
Published: (2020-04-01)

Association between hypertension and the prevalence of liver steatosis and fibrosis
by: Huanjie Fu, et al.
Published: (2023-04-01)

Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease
by: Ahmed M. F. Mansour, et al.
Published: (2020-09-01)

Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal
by: Dorotea Bozic, et al.
Published: (2022-09-01)

Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological Response
by: Anca Trifan, et al.
Published: (2022-03-01)

Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
by: V. P. Kovyazina, et al.
Published: (2021-04-01)

Hepatic Fibrosis and Steatosis in Metabolic Syndrome
by: Venu Gopala Reddy Gangireddy, et al.
Published: (2022-03-01)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
by: Jinwang Li, et al.
Published: (2021-12-01)

Quantification of Liver Fat Content with the iATT Algorithm: Correlation with Controlled Attenuation Parameter
by: Giovanna Ferraioli, et al.
Published: (2022-07-01)

Advanced fibrosis leads to overestimation of steatosis with quantitative ultrasound in individuals without hepatic steatosis
by: Takashi Kumada, et al.
Published: (2024-03-01)

Association between type 2 diabetes status and prevalence of liver steatosis and fibrosis among adults aged ≥ 40 years
by: Jun Chen, et al.
Published: (2022-05-01)

Insulin resistance and steatosis in chronic hepatitis C
by: Mariana V. Machado, et al.
Published: (2009-01-01)

Risk Factors for Hepatic Steatosis in Children
by: Yu.M. Stepanov, et al.
Published: (2016-04-01)

Diagnosis and quantification of fibrosis, steatosis, and hepatic siderosis through multiparametric magnetic resonance imaging
by: M. Stoopen-Rometti, et al.
Published: (2017-01-01)

Clinical and Anamnestic Features of Hepatic Steatosis in Children
by: N.Yu. Zavgorodnia, et al.
Published: (2015-11-01)

Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
by: Hesham Mohamed Atef, et al.
Published: (2023-12-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Evaluation of Hepatic Steatosis in Rodents by Time-Domain Nuclear Magnetic Resonance
by: João A.B. Pedroso, et al.
Published: (2019-11-01)

The liver steatosis severity and lipid characteristics in primary biliary cholangitis
by: Yuan Zhang, et al.
Published: (2021-10-01)

The inverse effect of meal intake on controlled attenuation parameter and liver stiffness as assessed by transient elastography
by: Kanittha Ratchatasettakul, et al.
Published: (2017-04-01)

Morphometric analysis of hepatic steatosis in chronic hepatitis C infection
by: Zubair Alia, et al.
Published: (2009-01-01)

Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model
by: Jae-Sung Ryu, et al.
Published: (2019-08-01)

Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population
by: Jieun Chung, et al.
Published: (2021-11-01)

Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single‐center observational study
by: Andrea Pasta, et al.
Published: (2021-10-01)

Protective Effects of Sesamol against Liver Oxidative Stress and Inflammation in High-Fat Diet-Induced Hepatic Steatosis
by: Wenya Zheng, et al.
Published: (2021-12-01)

Naringenin attenuates hepatitis B virus X protein-induced hepatic steatosis
by: Hung-Jen Lin, et al.
Published: (2017-11-01)

The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis
by: Danqing Hu, et al.
Published: (2024-04-01)

A new non-invasive method for assessing steatosis in chronic liver diseases
by: I G Bakulin, et al.
Published: (2016-02-01)